Could you send me an application form? <a href="http://barlens.com.au/opdivo-future-indications-72f7.pdf#constant">opdivo (nivolumab) fda approval</a>  The offer represents a 15 percent premium to GSW's three-month volume-weighted average share price and the company's net asset value (NAV), making it more expensive than other recent residential real estate deals.